297) The results demonstrate that rapid patient-side immunomigration assays design |
298) ections induced by BRSV by means of rapid patient-side immunomigration assays used f |
299) detailed understanding of the individual patient including their developmental stat |
300) important in the care of a critically ill patient, including the common errors to av |
301) ile educational interventions to increase patient motivation to pursue living donor |
302) nt determinants of effectiveness, such as patient's motivation and goal-directed reh |
303) A patient of 42 years is followed in Physica |
304) stimulating laser therapy in HIV-infected patients of varying degrees of immunodefic |
305) The patient outcome was fatal despite multimod |
306) ethodology for the case-mix adjustment of patient-reported outcome measures (PROMs) |
307) The FDS score for "Patient's pain and condition" was the high |
308) Patient pain rate, scar aesthetics and pat |
309) fter breast cancer surgery by examining a patient population from a tertiary cancer |
310) and be aware of its peculiarities in this patient population. |
311) rventions are widely recommended for this patient population, but to date no studies |
312) ms, they also occur in the critically ill patient population, where their presentati |
313) In addition, each patient received intravenous piracetam and |
314) The patient received radiation therapy postope |
315) apse 29 ± 21.65 weeks), and only one patient remained completely under control |
316) The patient remained well without evidence of |
317) The patient remains asymptomatic 1 year later. |
318) Currently, the patient remains asymptomatic under joined |
319) Although the patient reported slight discomfort for a f |
320) One patient reported that lymphedema worsened. |
321) nd rates of administration, and assessing patient response to therapy. |
322) The patient's response to recommended pharmaco |
323) Patient responses (n = 301, Spanish: 150, |
324) Patient responses were compared in terms o |
325) cillatory abnormalities in ASD as well as patient symptoms. |
326) The patient-reported symptoms and physical fin |
327) The young age of our patient, the absence of history of cardiov |
328) results suggest that the condition of the patient, the view of the caregiver on home |
329) sis of the jaw (BRONJ) in an osteoporotic patient treated with oral risedronate sodi |
|